| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/1997 | EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 01/08/1997 | EP0751944A1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents |
| 01/08/1997 | EP0751943A1 Triazole compounds and processes for the preparation thereof |
| 01/08/1997 | EP0751940A1 Sesquiterpenic derivatives |
| 01/08/1997 | EP0751939A1 Naphthylamides as central nervous system agents |
| 01/08/1997 | EP0751936A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor |
| 01/08/1997 | EP0751934A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751926A1 Enhancement of the efficacy of drugs by deuteration |
| 01/08/1997 | EP0751789A1 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751777A1 USE OF GINSENOSIDE R o? OR A PLANT EXTRACT CONTAINING SAME TO PROMOTE COLLAGEN SYNTHESIS |
| 01/08/1997 | EP0751776A1 Novel pharmaceutical composition for skin diseases |
| 01/08/1997 | EP0751775A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives |
| 01/08/1997 | EP0751774A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/08/1997 | EP0751773A1 Tocolytic oxytocin receptor antagonists |
| 01/08/1997 | EP0751772A1 New use of quinoline-3-carboxamide compounds |
| 01/08/1997 | EP0751771A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant |
| 01/08/1997 | EP0751770A1 8-substituted tetrahydro-beta-carbolines |
| 01/08/1997 | EP0751769A1 Medical treatment using thyroid hormones |
| 01/08/1997 | EP0751768A1 Anti-viral and anti-cancer agents |
| 01/08/1997 | EP0751767A1 Therapeutic guanidines |
| 01/08/1997 | EP0751766A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 01/08/1997 | EP0751765A1 Sulfonamide derivatives and their use |
| 01/08/1997 | EP0751764A1 Retinal-containing composition |
| 01/08/1997 | EP0751763A1 Substances, combinations of active substances and compositions against skin ageing |
| 01/08/1997 | EP0751762A1 Skin care product |
| 01/08/1997 | EP0751761A1 Active substances and compositions for the therapy of senile xerosis |
| 01/08/1997 | EP0751760A1 Method for the treatment and/or prevention of radiation burn |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0663909B1 Method of obtaining 10-deacetylbaccatine iii |
| 01/08/1997 | EP0588855B1 Acylated heparins as inhibitors of the replication of retroviruses |
| 01/08/1997 | EP0568577B1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 01/08/1997 | EP0558657B1 Retroviral protease inhibitors |
| 01/08/1997 | EP0551411B1 Ionically cross-linked polymeric microcapsules |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139929A Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1139927A Substituted morpholine derivatives and their use as therapeutic agents |
| 01/08/1997 | CN1139925A 'Delta' 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical compositions containing them |
| 01/08/1997 | CN1139917A Calcium receptor-active arylalkyl amines |
| 01/08/1997 | CN1139881A Aqueous topical compositions |
| 01/08/1997 | CN1139880A Diphenyl-2-propenoates and homologs thereof useful for threating diseases associated with leukotriene B4 |
| 01/08/1997 | CN1139879A Antimicrobial method and cosmetic composition |
| 01/08/1997 | CN1139667A Zinc P-acetlaminoacetate with anti ulcer and immunoregulation action |
| 01/08/1997 | CN1139666A Novel tricyclic amide, its preparation method and medicinal combination |
| 01/08/1997 | CN1139550A Making process for vitamin E nicotinate capsule |
| 01/08/1997 | CN1033752C (1H-A201-1Ylmethyl) ubstituted quinoline, quinazoline or quinoxaline derivatives |
| 01/08/1997 | CN1033751C Anti-bacteria optically active pyridonecarboxylic acid derivatives for treatment |
| 01/08/1997 | CN1033750C Intermediates useful in the production of aromatic amino-alcohol derivatives having antidiabetes and antiobesity properties |
| 01/07/1997 | US5591892 Allosteric modifiers of hemoglobin |
| 01/07/1997 | US5591887 13,14-dihydro-15-keto-pgfs |
| 01/07/1997 | US5591866 Neuroprotective agents |
| 01/07/1997 | US5591862 Tetrazole derivatives, their production and use |
| 01/07/1997 | US5591860 Retroviral protease inhibiting compounds |
| 01/07/1997 | US5591856 Chemical intermediates, treatment of alzheimer's disease |
| 01/07/1997 | US5591851 Antiviral compounds |
| 01/07/1997 | US5591840 Antisense oligonucleotides directed against nucleic acids encoding NFKB transcription factor |
| 01/07/1997 | US5591837 Macrolide antibiotic |
| 01/07/1997 | US5591835 Substituted lactose derivatives |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591777 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions |
| 01/07/1997 | US5591776 Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| 01/07/1997 | US5591775 Sleep disorders |
| 01/07/1997 | US5591774 Method of treating wrinkles using malic acid |
| 01/07/1997 | US5591773 Inhibition of cataract formation, diseases resulting from oxidative stress, and HIV replication by caffeic acid esters |
| 01/07/1997 | US5591772 Dietary supplements |
| 01/07/1997 | US5591771 Use of propolis components as an adjuvant |
| 01/07/1997 | US5591770 Calanolide and related antiretroviral compounds, compositions, and uses thereof |
| 01/07/1997 | US5591769 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 01/07/1997 | US5591768 Methods for treating circadian rhythm phase disturbances |
| 01/07/1997 | US5591767 Liquid reservoir transdermal patch for the administration of ketorolac |
| 01/07/1997 | US5591766 Bactericides |
| 01/07/1997 | US5591763 Imidazoles |
| 01/07/1997 | US5591762 Benzimidazoles useful as angiotensin-11 antagonists |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591758 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 01/07/1997 | US5591757 Dihydropyridine composition |
| 01/07/1997 | US5591755 Pyridinyl thiadiazolyl compounds for treating glaucoma |
| 01/07/1997 | US5591754 Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith |
| 01/07/1997 | US5591753 Combination treatment for osteoporosis |
| 01/07/1997 | US5591751 Peripheral vasodilators |
| 01/07/1997 | US5591749 Imidazopyridines as serotonergic 5-HT3 -antagonists |
| 01/07/1997 | US5591746 Glutamate inhibitors; central nervous system disorders |
| 01/07/1997 | US5591745 (4-heteroaryl)-1-[(2,3-dihydro-1H-isoindol-2-yl)alkyl] piperidines and related compounds and their therapeutic utility |
| 01/07/1997 | US5591744 1,4-dihydro-4-oxoquinoline-3-carboxylate derivatives; microbiocides |
| 01/07/1997 | US5591743 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives as 5HT1A ligands |
| 01/07/1997 | US5591742 Treatment of angina, hypertension, atherosclerosis, cardiovascular disorders |
| 01/07/1997 | US5591740 Use of debromohymenialdisine for treating osteoarthritis |
| 01/07/1997 | US5591738 Method of treating chemical dependency using β-carboline alkaloids, derivatives and salts thereof |
| 01/07/1997 | US5591736 Method of retarding the progression of chronic renal failure |
| 01/07/1997 | US5591735 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same |
| 01/07/1997 | US5591734 17-(3-furyl)-5β, 14β-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/07/1997 | US5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/07/1997 | US5591732 Administering 4-chloro-1-dehydromethyltestosterone and/or mestanolone to treat osteoporosis |
| 01/07/1997 | US5591731 Crystalline amifostine compositions |
| 01/07/1997 | US5591730 Inhibition of urinary calculi growth |